Arkolith/Insider Trading/CRBP/Form 4

Cohen Yuval

Chief Executive Officer, DirectorCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Feb 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$108K
Net Open-Market Flow
-$108K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 13, 2026Sell(S)14K$7.78$108K174K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-057159) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML